US approves first new Alzheimer’s drug in almost two decades

Published by
AFP

Washington (AFP) – The United States on Monday approved a drug called Aduhelm to treat patients with Alzheimer’s, the first new medicine against the disease in almost two decades and the first to address cognitive decline linked to the condition. The decision was highly anticipated but also contentious, because an independent expert panel convened by the regulatory Food and Drug Administration last November found insufficient evidence of Aduhelm’s benefit and recommended against approval. “Aduhelm is the first treatment directed at the underlying pathophysiology of Alzheimer’s disease, the pre…

Read More

Share this Story
Load More Related Articles
Load More In US News

Facebook Comments

Check Also

Exclusive-WHO estimates COVID-19 boosters needed yearly for most vulnerable

Published by Reuters By Francesco Guarascio BRUSSELS (Reuters) ...

Archives